This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Jeremy Lanfear: Innovator in Genetic Modulation
Introduction
Jeremy Lanfear is a notable inventor based in the County of Kent, GB. He has made significant contributions to the field of genetic engineering, particularly in the modulation of PDE11A activity. His work has implications for understanding spermatogenesis and related biological processes.
Latest Patents
Lanfear holds a patent for the invention titled "Modulation of PDE11A activity." This invention provides genetically-modified non-human mammals and genetically-modified animal cells that contain a functionally disrupted PDE11A gene. The patent also outlines methods for screening agents that modulate PDE11A to influence spermatogenesis. Additionally, it includes methods for treating mammals to modulate spermatogenesis and techniques for modulating cAMP and cGMP signal transduction in cells expressing PDE11A. He has 1 patent to his name.
Career Highlights
Jeremy Lanfear is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development in the field of genetics and pharmaceuticals.
Collaborations
Lanfear has collaborated with notable colleagues, including Martyn Frank Burslem and Ian Dennis Harrow. These collaborations have likely contributed to the advancement of his research and the successful development of his patent.
Conclusion
Jeremy Lanfear's innovative work in genetic modulation highlights the potential for advancements in medical science. His contributions to the understanding of PDE11A activity are paving the way for future research and applications in spermatogenesis and beyond.